Medinotec (MDNC) Cash from Operations Growth (1y) (2023 - 2026)
Powered by 
Analysis
Medinotec (MDNC) Cash from Operations Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -12.60% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 76.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 76.80% |
| Feb 28, 2026 | -123.03% |
| Nov 30, 2025 | 307.50% |
| Aug 31, 2025 | 190.19% |
| May 31, 2025 | -392.99% |
| Feb 28, 2025 | 7,032.16% |
| Nov 30, 2024 | -63.87% |
| Aug 31, 2024 | 6,548.96% |
| May 31, 2024 | 194.33% |
| Feb 29, 2024 | -101.31% |
| Nov 30, 2023 | 254.18% |
| Aug 31, 2023 | 98.77% |
| May 31, 2023 | -302.77% |
| Feb 28, 2023 | 360.99% |